Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.37x is 207% below its 4-year average of 0.35x, near the low end of its 4-year range (-0.98x–3031.00x).
13.10% above its 12-month average of -0.43x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-05-31): 0.22x.
INTEREST COVERAGE RATIO
-0.37x
INTEREST COVERAGE RATIO AVG TTM
-0.43x
INTEREST COVERAGE RATIO AVG 3Y
0.36x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.10%
CURRENT VS 3Y AVG
-202.78%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 459 covered companies
CURRENT VS SECTOR MEDIAN
+93.45%
vs the sector median at left
Neogen Corporation
Market Cap
$2.67B
Interest Coverage Ratio
-0.37x
TTM Avg
-0.43x
3Y Avg
0.36x
5Y Avg
N/A
Market Cap
$2.68B
Interest Coverage Ratio
1.89x
TTM Avg
1.89x
3Y Avg
0.94x
5Y Avg
0.94x
Market Cap
$2.69B
Interest Coverage Ratio
2.79x
TTM Avg
3.64x
3Y Avg
5.04x
5Y Avg
5.11x
Market Cap
$2.71B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.61B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.60B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.58B
Interest Coverage Ratio
N/A
TTM Avg
7.78x
3Y Avg
5.30x
5Y Avg
5.30x
Market Cap
$2.80B
Interest Coverage Ratio
-0.59x
TTM Avg
11.23x
3Y Avg
11.23x
5Y Avg
11.23x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.67B | -0.37x | -0.43x | 0.36x | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 1.89x | 1.89x | 0.94x | 0.94x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 2.79x | 3.64x | 5.04x | 5.11x |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | N/A | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.72B | -27.57x | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | -8.77x | N/A | N/A | N/A |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | N/A | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | N/A | 7.78x | 5.30x | 5.30x |
| AtriCure, Inc. (ATRC)vs › | $2.80B | -0.59x | 11.23x | 11.23x | 11.23x |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 7.88x | 5.24x | 5.24x | 5.24x |
Interest Coverage
-0.4x
Debt/Equity
0.38
Current Ratio
3.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-05-31 | 0.22x |
| 2026-02-28 | -0.24x |
| 2025-11-30 | -0.36x |
| 2025-08-31 | -0.98x |
| 2025-05-31 | -0.77x |
| 2025-02-28 | 0.68x |
| 2024-11-30 | 0.94x |
| 2024-08-31 | 0.47x |
| 2024-05-31 | 0.94x |
| 2024-02-29 | 0.64x |
| 2023-11-30 | 0.80x |
| 2023-08-31 | 1.04x |
| 2023-05-31 | 1.30x |
| 2023-02-28 | 0.90x |
| 2022-11-30 | -0.37x |
| 2022-08-31 | 3031.00x |
| 2022-02-28 | 182.20x |
| 2021-11-30 | 566.77x |
